Cellbricks Therapeutics

Company profile

Cellbricks Therapeutics company profile

Cellbricks, a global leader in tissue and organ replacement technologies, develops advanced soft and liver tissue implants for over a hundred million patients facing serious wounds or severe liver disease. The company's biofabrication platform, validated in vivo and in daily use at its clinical manufacturing partner, enables the scalable production of large, immune-compatible tissue therapeutics that precisely mimic human physiology. By combining a variety of biomaterials and cell types, seamless integration and functionality is achieved. Cellbricks aims to eliminate the need for autologous tissue transfers and the long wait for donor organs, ultimately enabling patients to live longer, healthier lives.